Latest Market Competition News

ReNerve Limited has achieved a key milestone with its first sale and clinical use of a deep dermal tissue product in the US, broadening its surgical applications beyond nerve repair. This move complements its existing nerve repair portfolio and sets the stage for further product launches later this year.

betr Entertainment Limited has lodged a replacement bidder’s statement enhancing its all-scrip takeover offer for PointsBet Holdings Limited, promising significant cost synergies and a stronger foothold in Australia’s wagering market.

QBE Insurance Group reported a robust half-year performance with a 27% jump in net profit and a 6% rise in gross written premium, underpinned by strong underwriting and investment returns. The insurer declared a higher interim dividend, signaling confidence in its growth trajectory.

Image Resources NL is broadening its project development focus beyond the newly commissioned Atlas mine, aiming to mitigate regulatory risks and ensure operational continuity through multiple potential mining projects.

NoviqTech Limited has expanded its sustainability technology footprint through key partnerships in hydrogen and battery recycling, secured a significant grant extension, and announced a $1.25 million capital raise to fuel growth.

RemSense Technologies closed FY2025 with a positive EBITDA and expanding virtualplant platform usage among major clients, setting the stage for significant growth in FY2026. The company’s strategic hires and new contracts highlight its rising footprint in industrial digital transformation.

BluGlass Limited has secured its first order from the Indian Department of Defence and reported a significant 16% improvement in visible laser efficiency, alongside raising $7.6 million to support growth.

The Commerce Commission has issued a Statement of Issues regarding Viridian NZ Bidco’s proposed acquisition of Metro Glass, highlighting potential competition risks in New Zealand’s glass processing and installation markets.

Patrys Limited has announced a fully underwritten entitlement offer to raise approximately $1.77 million, aimed at funding ongoing research and development of its PAT-DX3 therapy and supporting working capital. The offer includes secondary options and shares, subject to shareholder approval, and will significantly expand the company's capital base.

Lumos Diagnostics reported a 12% revenue increase for FY25 and inked a landmark US$317 million exclusive distribution deal for its FebriDx test, while advancing its FDA CLIA waiver application.

Nova Eye Medical has reported a record A$28.8 million in revenues for FY25, driven by strong US sales and sustained growth of its flagship iTrack™ Advance device.

PointsBet Holdings Limited has updated its FY25 financial outlook, signalling that both revenue and EBITDA are expected to land at the bottom of previously forecasted ranges.